Cytogenetic evaluation in myelodysplastic syndrome (MDS) has been considered important not only for clonality determination at diagnosis, but also for prognosis. 1 Recently, the International Prognostic Scoring 
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System has proposed identified chromosomal abnormalities as one of the most important variables to determine survival and to predict the risk of transformation into acute leukaemia 2 . Loss of material from chromosome 5 as a result of monosomy or deletion is quite common and occurs in 10-30% of patients with MDS who show chromosomal aberrations. 3 The 5q-syndrome is a MDS with the 5q deletion as the sole karyotypic abnormality and is characterised by refractory macrocytic anaemia, hypolobulated megakaryocytes in bone marrow, and a low risk of transformation to acute myeloid leukaemia. 4 This group of patients has a favourable prognosis compared with groups who have other chromosomal aberrations. The bone marrow cytologic and histologic evaluations showed hypercellularity of the erythroid, granulocytic and megakaryoblastic lineages, with atypical erythroblasts and a great number of small and hypolobulated megakaryocytes (Figure 1 ). The karyotype was 46,XX,del(5)(q13q33) (Figure 2) .
The patient has been seen in our service for two years, without red blood cell transfusions or transformation to acute leukaemia. 
